Facially amphiphilic skeleton-derived antibacterial crown ether/silver ion complexes

Area of Science:

• Nanotechnology
• Materials Science
• Medicinal Chemistry

Background:

• Silver compounds are known for antibacterial properties but are limited by biological toxicity.
• Developing safer and more effective silver-based antimicrobials is crucial for treating bacterial infections.

Purpose of the Study:

• To design and synthesize a novel facially amphiphilic skeleton-derived silver complex (D-CA₆-CE/Ag⁺).
• To evaluate the antibacterial activity and biological toxicity of the novel complex compared to silver sulfadiazine.

Main Methods:

• Synthesis of a dendrimer D-CA₆-CE incorporating crown ether moieties for silver ion chelation.
• Characterization of the self-assembly of D-CA₆-CE/Ag⁺ into nano-micelles in aqueous solution.
• Determination of minimum inhibitory concentrations (MICs) against *Escherichia coli* and *Staphylococcus aureus*.
• Assessment of hemolysis and cytotoxicity to evaluate biological safety.

Main Results:

• D-CA₆-CE/Ag⁺ self-assembles into nano-micelles, significantly reducing silver ion MICs to 6.13 μg mL^-1 (*E. coli*) and 7.33 μg mL^-1 (*S. aureus*).
• The complex demonstrated superior antibacterial efficacy compared to silver sulfadiazine, attributed to enhanced bacterial membrane disruption.
• D-CA₆-CE/Ag⁺ exhibited significantly lower hemolysis and cytotoxicity, likely due to its micellar structure minimizing direct cell contact.

Conclusions:

• The facially amphiphilic D-CA₆-CE/Ag⁺ complex presents enhanced antibacterial performance and reduced biological toxicity.
• This novel silver complex holds promise as a potential therapeutic agent for bacterial infections.